Cell Therapy Next Current Issue

The following articles appeared in the print edition of Cell Therapy Next.

Table of Contents

• From Research to Manufacturing to Treatment: A One-Stop CAR T Shop Katrina Altersitz
• Patient Selection: The Key First Step to Successful CAR T-cell Therapy
• A Phase I/II Study Administering Peripheral Blood Lymphocytes (PBL) Transduced With a CD70-Binding Chimeric Antigen Receptor to Patients With CD70 Expressing Cancers
• CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer
• EGFR806 CAR T-cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
• GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children with Neuroblastoma
• HER2-CAR T-cells in Treating Participants with Brain or Leptomeningeal Metastases
• Use of Ligand-Inducible Autologous T-cells Engineered to Target PSCA on Tumor Cells in Selected Advanced Solid Tumors
• Welcome to the Premier Issue of Cell Therapy Next
• Pediatric CAR T-cell Therapy Guidelines Highlight Need for Interdisciplinary Monitoring
• Collaborative Aims to Accelerate Immunotherapy Development for Pediatric Cancers
• UK Panel Initially Rejects CAR T-cell Therapy Due to Cost
• UK Panel Rejects Kymriah for Adults With Lymphoma Due to Cost
• UK Panel Reverses Decision, Now Recommends Covering Yescarta